SEATTLE--(BUSINESS WIRE)--Rosetta Biosoftware, a leader in life science informatics solutions, today announced that the Rosetta Syllego™ system has achieved GeneChip-compatibleTM status for use with the Affymetrix microarray platform. This compatibility enables research organizations conducting genome-wide association and other genetic studies to focus on revealing genetic risk factors and therapies for diseases, such as coronary artery disease, type 2 diabetes, and other complex diseases.
